References
- Nettleship. On cases of retro-ocular neuritis. Trans Ophthalmol Soc UK. 1884;4:186–226.
- Sandberg-Wollheim M, Bynke H, Cronqvist S, Holtas S, Platz P, Ryder LP. A long-term prospective study of optic neuritis: evaluation of risk factors. Ann Neurol. 1990;27:386–393.
- Optic Neuritis Study Group. The clinical profile of optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol. 1991;109:1673–1678.
- Beck RW, Trobe JD. What we have learned from the optic neuritis treatment trial. Ophthalmol. 1995; 102:1504–1508.
- Jin YP, de Pedro-Cuesta J, Söderström M, Stawiarz L, Link H. Incidence of optic neuritis in Stockholm, Sweden 1990–1995. I. Age, sex, birth and ethnic-group related patterns. J Neurol Sci. 1998;159: 107–114.
- Wakakura M, Minei-Higa R, Oono S, et al. Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Jpn J Ophthalmol. 1999;43:127–132.
- Cohen MM, Lessell S, Wolf PA. A prospective study of the risk of developing multiple sclerosis in uncomplicated optic neuritis. Neurology. 1979;29:208–213.
- Isayama Y, Takahashi T, Shimoyama T, Yamadori A. Acute optic neuritis and multiple sclerosis. Neurology. 1982;32:73–76.
- Miller DH, Newton MR, Van der Poel JC, et al. Magnetic resonance imaging of the optic nerve in optic neuritis. Neurology. 1988;38:175–179.
- Alter M, Leibowitz U, Speer J. Risk of multiple sclerosis related to age at immigration to Israel. Arch Neurol. 1966;15:234–237.
- Percy AK, Nobrega FT, Kurland LT. Optic neuritis and multiple sclerosis: an epidemiologic study. Arch Ophthalmol. 1972;87:135–139.
- Wikström J. The epidemiology of optic neuritis in Finland. Acta Neurol Scand. 1975;52:196–206.
- Kahana E, Alter M, Feldman S. Optic neuritis in relation to multiple sclerosis. J Neurol. 1976; 213:87–95.
- Haller P, Patzold U, Eckert G. Optic neuritis in Hanover: an epidemiologic and serogenetic study. In: Bauer HJ, Poser S, Ritter G, editors. Progress in multiple sclerosis research. Berlin, Heidelberg: Springer-Verlag, 1980;546–548.
- Kinnunen E. The incidence of optic neuritis and its prognosis for multiple sclerosis. Acta Neurol Scand. 1983;68:371–377.
- Rodriguez M, Siva A, Cross SA, O'Brien PC, Kurland LT. Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology. 1995;45:244–250.
- Kuroiwa Y, Igata A, Itahara K, et al. Nationwide survey of multiple sclerosis in Japan: clinical analysis of 1,084 cases. Neurology. 1975;25: 845–851.
- Shibasaki H, McDonald WI, Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J Neurol Sci. 1081;40:253–271.
- McDonald WI. Doyne Lecture: the significance of optic neuritis. Trans Ophthalmol Soc UK. 1983;1o3: 230–246.
- Beck RW. Optic neuritis. In: Miller NR, Newman NJ, editors. Walsh & Hoyt's clinical neuro-ophthalmology, 5th ed, Vol 1. Baltimore: Williams & Willkins, 1008;500–647.
- Smith JL, McCrary JA, Bird AC, et al. Sub-Tenon steroid injection for optic neuritis. Trans Am Acad Ophthalmol. I970:74:1240-1253.
- Bird AC, Leaver PK, Gould E, McDonald I. Assessment of intraconal steroids in the treatment of retrobulbar neuritis. In: Glaser JS, editor. Neuro-ophthalmology. Saint Louis: The CV Mosby Company, 1977; 154–159.
- Beck RW, Cleary PA, the Optic Neuritis Study Group. Optic Neuritis Treatment Trial: one-year follow-up results. Arch Ophthalmol. 1993;111;773–775.